CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
89 hedge funds and large institutions have $116M invested in CTI BioPharma Corp. (DE) Common Stock in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
-4
Holders Change %
-4.3%
% of All Funds
2.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
25
Reduced
27
Closed
24
Calls
$2.46M
Puts
$608K
Net Calls
+$1.85M
Net Calls Change
+$8.19M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$1.95M |
| 2 |
TA
Teachers Advisors
New York
|
+$1.8M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.27M |
| 4 |
Millennium Management
New York
|
+$1.01M |
| 5 |
Jane Street
New York
|
+$911K |
Top Sellers
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$4.59M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.4M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.16M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.34M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.76M |
